Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > NanoBusiness Alliance Announces Participation in Livingston Healthcare & Life Sciences Summit, Debuting in NYC September 10th With Focus on “Capturin

Abstract:
The NanoBusiness Alliance today announced that Vice President Vincent Caprio will be participating in the debut of The Livingston Healthcare & Life Science Stakeholders Summit - "Capturing Trends and Global Outlook: Advanced and Nano Technologies," being held on September 10, 2008 at the Renaissance Hotel Times Square in New York City.

NanoBusiness Alliance Announces Participation in Livingston Healthcare & Life Sciences Summit, Debuting in NYC September 10th With Focus on “Capturin

New York, NY | Posted on August 27th, 2008

"Over the past three years, the Axiom Capital Management/Livingston Nanotechnology Conference has emerged as an important gathering for the investment community and pioneers in the area of nanotechnology," said Vincent Caprio, Vice President and Event Director, NanoBusiness Alliance. "I'm excited to be presenting at Scott Livingston's new event, with a focus on the tremendous opportunities for nanotechnology in the field of healthcare and life science."

The summit is a unique and by invitation-only conference designed around three important global issues for investors:

* Drug Discovery and Development: Early to Mid-Stage
* Diagnostics: Valuation and Future Directions
* Global and Emerging Investment Opportunities

Invitees include CEOs, CFOs, COOs for a broad range of pharmaceutical, diagnostic, and platform technology companies, a select number of US and International VCs and PEs, along with key policy makers and federal science and regulatory agencies.

"Our Healthcare & Life Sciences Summit has been designed to bring together key stakeholders from pharmaceutical, capital investment, business strategy and federal science and regulatory segments," said Scott Livingston, managing director of Axiom Capital Management, and head of the Livingston Group, a division within Axiom that focuses on nanotechnology. "Due to its exclusive nature, we can assure that in addition to helping attendees identify key trends, the event will provide for significant opportunities among participants for deal making."

For information on registering for the Livingston Healthcare & Life Sciences Summit, please contact Jonathan Mason at .

####

About NanoBusiness Alliance
The NanoBusiness Alliance is the industry association for the emerging nanotechnology industry. Through its extensive network of leading startups, Fortune 500 companies, research institutions, non-governmental organizations and public-private partnerships, the Alliance shapes nanotechnology policy and helps accelerate the commercialization of nanotechnology innovations.

About Axiom Capital Management Inc. and the Livingston Group

Axiom Capital Management Inc. is a FINRA registered broker/dealer that works with growth companies and institutional investors and provides corporate finance, prime brokerage and private equity opportunities to a wide range of customers.

The Livingston Group was formed by Scott Livingston, who joined Axiom Capital Management Inc. in 2005 after a 15-year career on Wall Street, and has been working exclusively on nanotechnology investments since 2002. Scott has been called "sharp and highly connected” by the Forbes Wolfe Nanotechnology Report (July 1, 2005) and has been an invited speaker on nanotechnology investment trends at MIT, the Harvard Club, the Nanobusiness Alliance, the Cambridge Healthtech Institute, Nanotechnology.com, the International Business Forum, Albany Nanotech, the Delaware Technology Park, the Business Executives for National Security, Hillary Clinton's Jobs for New York, WXXA Fox 23, Cold Spring Harbor's Dolan DNA Learning Center and has presented to half a dozen state pension leaders across the country. Scott is also the creator of the annual Axiom Capital Management "Livingston Nanotechnology Conference," one of the best attended nanotechnology forums of the year.

For more information, please click here

Contacts:
Schwartz Public Relations
Steven Wright-Mark
212-677-8700 ext. 29

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Nanoparticles Increase Durability of Concrete Decorations in Cold Areas January 26th, 2015

Iranian Researchers Boost Solar Cells Efficiency Using Anti-Aggregates January 26th, 2015

Detection of Heavy Metals in Samples with Naked Eye January 26th, 2015

Engineering self-assembling amyloid fibers January 26th, 2015

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

Ref signals deep impact as EPSRC announces £30 million for impact acceleration accounts (IAA) January 21st, 2015

Blend Therapeutics Secures $21 Million Financing and Unveils Novel Pentarin™ Platform for Cancer Therapeutics: Company’s Technology and Expertise in Cancer R&D Evolve to Create New Class of Miniaturized Biologic Drug Conjugates (mBDCs) Encapsulated in Nanoparticles January 8th, 2015

QD Vision Receives New Funding Round to Meet Growing Demand for Quantum Dot Technology: Industry Veteran Steve Ward Named Executive Chairman January 5th, 2015

Pixelligent Closes $5.5 Million in Funding: Capital Will Be Used to Support Global Customer Growth December 12th, 2014

Investments/IPO's/Splits

Malaysian Nanotechnology Company Nanopac Innovation Ltd. lists on the NSX January 19th, 2015

Aspen Aerogels, Inc. to Present at the Needham Growth Conference January 8th, 2015

Blend Therapeutics Secures $21 Million Financing and Unveils Novel Pentarin™ Platform for Cancer Therapeutics: Company’s Technology and Expertise in Cancer R&D Evolve to Create New Class of Miniaturized Biologic Drug Conjugates (mBDCs) Encapsulated in Nanoparticles January 8th, 2015

Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 2, 2015 January 7th, 2015

Nanomedicine

Engineering self-assembling amyloid fibers January 26th, 2015

Promising use of nanodiamonds in delivering cancer drug to kill cancer stem cells: NUS study shows that delivery of Epirubicin by nanodiamonds resulted in a normally lethal dosage of Epirubicin becoming a safe and effective dosage for treatment of liver cancer January 26th, 2015

Teijin to Participate in Nano Tech 2015 January 22nd, 2015

2nd International Conference on Infectious Diseases & Nanomedicine (December 15-18, 2015, Kathmandu, NEPAL) January 22nd, 2015

Announcements

Nanoparticles Increase Durability of Concrete Decorations in Cold Areas January 26th, 2015

Iranian Researchers Boost Solar Cells Efficiency Using Anti-Aggregates January 26th, 2015

Detection of Heavy Metals in Samples with Naked Eye January 26th, 2015

Engineering self-assembling amyloid fibers January 26th, 2015

Events/Classes

Toyocolor to Launch New Carbon Nanotube Materials at nano tech 2015 January 24th, 2015

NANOPOSTER 2015 - 5th Virtual Nanotechnology Conference - call for abstracts January 24th, 2015

New conductive coatings for flexible touchscreens – presentation at nano tech 2015 in Japan January 22nd, 2015

Teijin to Participate in Nano Tech 2015 January 22nd, 2015

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2015 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE